dc.contributor
[Not A, Martró E] Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Servei de Microbiologia, Laboratori Clínic de la Metropolitana Nord (LCMN), Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Spain. Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. [Ouaarab-Essadek H, Treviño B, Gómez i Prat J] Equip de Salut Pública i Comunitària (eSPIc), Unitat de Salut Internacional Drassanes-Vall d’Hebron, Barcelona, Spain. [Montoro M] Centre d'Estudis Epidemiològics Sobre les ITS i la Sida de Catalunya (CEEISCAT), Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Spain. [Buti M] Servei d’Hepatologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Consorcio de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Morillas RM] Consorcio de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. Unitat d’Hepatologia, Departament Digestiu, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. [Bordoy AE] Servei de Microbiologia, Laboratori Clínic de la Metropolitana Nord (LCMN), Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Spain. [Folch C, Casabona J] Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Centre d'Estudis Epidemiològics Sobre les ITS i la Sida de Catalunya (CEEISCAT), Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Spain. [Majó X] Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
dc.contributor
Departament de Salut
dc.contributor.author
Not, Anna
dc.contributor.author
Ouaarab Essadek, Hakima
dc.contributor.author
Morillas, Rosa Maria
dc.contributor.author
Bordoy, Antoni E.
dc.contributor.author
Majó, Xavier
dc.contributor.author
Martró, Elisa
dc.contributor.author
Montoro Fernández, Marcos
dc.contributor.author
Treviño Maruri, Begoña
dc.contributor.author
Buti Ferret, Maria
dc.contributor.author
Folch, Cinta
dc.contributor.author
Casabona-Barbarà, Jordi
dc.contributor.author
Gómez i Prat, Jordi
dc.date.accessioned
2025-10-24T10:32:06Z
dc.date.available
2025-10-24T10:32:06Z
dc.date.issued
2025-06-06T09:10:49Z
dc.date.issued
2025-06-06T09:10:49Z
dc.identifier
Not A, Ouaarab-Essadek H, Montoro M, Treviño B, Buti M, Morillas et al. Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action. Liver Int. 2025 Jun;45(6):e70126.
dc.identifier
http://hdl.handle.net/11351/13221
dc.identifier
10.1111/liv.70126
dc.identifier.uri
http://hdl.handle.net/11351/13221
dc.description.abstract
Community action; Dried blood spots (DBS); Hepatitis B virus (HBV); Hepatitis C virus (HCV)
dc.description.abstract
Acción comunitaria; Gotas de sangre seca (GDS); Virus de la hepatitis B (VHB); Virus de la hepatitis C (VHC)
dc.description.abstract
Acció comunitària; Gotes de sang seca (GDS); Virus de l'hepatitis B (VHB); Virus de l'hepatitis C (VHC)
dc.description.abstract
Migrants from endemic areas are key populations for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection screening in Europe. This study assessed the feasibility and outcomes of a community action that combined education, screening, and simplified access to care for migrants in Barcelona.
Adult migrants from Pakistan, Romania, and Senegal were included from 2021 to 2023, through a community action involving education, an epidemiological questionnaire, and rapid testing for HBV surface antigen (HBsAg) and HCV antibodies. If positive, DBS samples were collected for laboratory confirmation. Viremic cases were referred to an International Health Unit (IHU).
Overall, 786 participants were included (346 from Pakistan, 304 from Senegal and 136 from Romania). Previous screening for HBV and HCV was 8.0% and 7.7%, respectively. HBsAg prevalence was 0.9% for migrants from Pakistan, 8.2% for those from Senegal and 1.4% for those from Romania (n = 30/786, 23 new diagnoses). Among these, 69.6% attended the IHU and were HBV-DNA positive, but none met treatment criteria. Anti-HCV prevalence was 3.5%, 0.7% and 1.4% for migrants from Pakistan, Senegal and Romania, respectively (n = 16/768, 12 new diagnoses), and HCV-RNA prevalence was 0.9%, 0.3% and 0.7%, respectively (N = 6, all new diagnoses); 4 (66.6%) cases were linked to treatment and two were cured.
This novel community action successfully reached migrants in a situation of vulnerability and provided them access to testing and care. The high prevalence observed and the limited self-knowledge of their HBV and HCV status justify targeted screening in these groups.
dc.format
application/pdf
dc.publisher
Wiley Online Library
dc.relation
Liver international;45(6)
dc.relation
https://www.doi.org/10.1111/liv.70126
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights
Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Cribatge (Medicina)
dc.subject
Riscos per a la salut - Avaluació
dc.subject
Serveis comunitaris de salut
dc.subject
Immigrants - Barcelona
dc.subject
DISEASES::Virus Diseases::DNA Virus Infections::Hepadnaviridae Infections::Hepatitis B
dc.subject
DISEASES::Virus Diseases::Hepatitis, Viral, Human::Hepatitis C
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Mass Screening
dc.subject
HEALTH CARE::Health Services Administration::Patient Care Management::Delivery of Health Care::Health Services Accessibility
dc.subject
ENFERMEDADES::virosis::infecciones por virus ADN::infecciones por Hepadnaviridae::hepatitis B
dc.subject
ENFERMEDADES::virosis::hepatitis viral humana::hepatitis C
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::cribado sistemático
dc.subject
ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::prestación sanitaria::accesibilidad a los servicios de salud
dc.title
Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion
